Dermatologicals in Uruguay

Abstract
As consumers adjusted to the “new normal” in the aftermath of the COVID-19 pandemic, dermatologicals showed a robust recovery in 2022, witnessing double-digit growth in retail current value terms. Previously dynamic categories, such as antiparasitic/lice (head and body) treatments, saw demand plummet in 2021 as a consequence of COVID-19 pandemic, which abruptly disrupted school life and children’s everyday activities in general. A return to normal schooling and pre-pandemic lifestyles in general...

Euromonitor International's Dermatologicals in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Dermatologicals in Uruguay

List Of Contents And Tables

DERMATOLOGICALS IN URUGUAY
KEY DATA FINDINGS
2022 DEVELOPMENTS
Robust recovery in 2022 as consumers return to more normal lifestyles
Continuing focus on hygiene sustains demand for topical antifungals
Megalabs remained in top position with a wide portfolio
PROSPECTS AND OPPORTUNITIES
Further recovery expected for dermatological sales
New product development expected to increase added-value choice over the forecast period
Further development of online sales expected, following lockdown expansion
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2017-2022
Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 5 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN URUGUAY
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources